Inibidores de cotransportador 1 de glicose de sódio e composição farmacêutica que os compreende

inibidores de cotransportador 1 de glicose de sódio. a presente invenção refere-se a inibidores de cotransportador 1 de glicose de sódio (sglt1), composições que os compreendem, e métodos de seu emprego para tratar doenças e distúrbios tais como diabetes. compostos particulares são da fórmula (i): (...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ZAMBROWICZ BRIAN, KENNETH GORDON CARSON, STROBEL ERIC, BRYCE ALDEN HARRISON, DAVID BRENT RAWLINS, NICOLE CATHLEEN GOODWIN
Format:	Patent
Sprache:	por
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	ZAMBROWICZ BRIAN KENNETH GORDON CARSON STROBEL ERIC BRYCE ALDEN HARRISON DAVID BRENT RAWLINS NICOLE CATHLEEN GOODWIN
description	inibidores de cotransportador 1 de glicose de sódio. a presente invenção refere-se a inibidores de cotransportador 1 de glicose de sódio (sglt1), composições que os compreendem, e métodos de seu emprego para tratar doenças e distúrbios tais como diabetes. compostos particulares são da fórmula (i): (i) cujos vários substituintes estão definidos aqui. Inhibitors of sodium glucose cotransporter 1 (SGLT1), compositions comprising them, and methods of their use to treat diseases and disorders such as diabetes are disclosed. Particular compounds are of the formula:the various substituents of which are defined herein.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112015011298B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112015011298B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112015011298B13</originalsourceid><addsrcrecordid>eNqNijEKAjEQANNYiPqHbSyFiyJoe6JoK_bHmuxJ4C4bs7kXWQi2PiEf8058gNUMw4yVOXl3dZYjCVgCwymil8AxYR9BD_HWOMNCg0p-W8cwjG1gcfmZHww1xhZNfnXJGYR7R8DyPSKRtzRVoxobodmPEzU_7C-744ICVyQBDXlKVXnWelnoddFjuyn16t_vA7PEQlg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inibidores de cotransportador 1 de glicose de sódio e composição farmacêutica que os compreende</title><source>esp@cenet</source><creator>ZAMBROWICZ BRIAN ; KENNETH GORDON CARSON ; STROBEL ERIC ; BRYCE ALDEN HARRISON ; DAVID BRENT RAWLINS ; NICOLE CATHLEEN GOODWIN</creator><creatorcontrib>ZAMBROWICZ BRIAN ; KENNETH GORDON CARSON ; STROBEL ERIC ; BRYCE ALDEN HARRISON ; DAVID BRENT RAWLINS ; NICOLE CATHLEEN GOODWIN</creatorcontrib><description>inibidores de cotransportador 1 de glicose de sódio. a presente invenção refere-se a inibidores de cotransportador 1 de glicose de sódio (sglt1), composições que os compreendem, e métodos de seu emprego para tratar doenças e distúrbios tais como diabetes. compostos particulares são da fórmula (i): (i) cujos vários substituintes estão definidos aqui. Inhibitors of sodium glucose cotransporter 1 (SGLT1), compositions comprising them, and methods of their use to treat diseases and disorders such as diabetes are disclosed. Particular compounds are of the formula:the various substituents of which are defined herein.</description><language>por</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; SUGARS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211214&DB=EPODOC&CC=BR&NR=112015011298B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211214&DB=EPODOC&CC=BR&NR=112015011298B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZAMBROWICZ BRIAN</creatorcontrib><creatorcontrib>KENNETH GORDON CARSON</creatorcontrib><creatorcontrib>STROBEL ERIC</creatorcontrib><creatorcontrib>BRYCE ALDEN HARRISON</creatorcontrib><creatorcontrib>DAVID BRENT RAWLINS</creatorcontrib><creatorcontrib>NICOLE CATHLEEN GOODWIN</creatorcontrib><title>Inibidores de cotransportador 1 de glicose de sódio e composição farmacêutica que os compreende</title><description>inibidores de cotransportador 1 de glicose de sódio. a presente invenção refere-se a inibidores de cotransportador 1 de glicose de sódio (sglt1), composições que os compreendem, e métodos de seu emprego para tratar doenças e distúrbios tais como diabetes. compostos particulares são da fórmula (i): (i) cujos vários substituintes estão definidos aqui. Inhibitors of sodium glucose cotransporter 1 (SGLT1), compositions comprising them, and methods of their use to treat diseases and disorders such as diabetes are disclosed. Particular compounds are of the formula:the various substituents of which are defined herein.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijEKAjEQANNYiPqHbSyFiyJoe6JoK_bHmuxJ4C4bs7kXWQi2PiEf8058gNUMw4yVOXl3dZYjCVgCwymil8AxYR9BD_HWOMNCg0p-W8cwjG1gcfmZHww1xhZNfnXJGYR7R8DyPSKRtzRVoxobodmPEzU_7C-744ICVyQBDXlKVXnWelnoddFjuyn16t_vA7PEQlg</recordid><startdate>20211214</startdate><enddate>20211214</enddate><creator>ZAMBROWICZ BRIAN</creator><creator>KENNETH GORDON CARSON</creator><creator>STROBEL ERIC</creator><creator>BRYCE ALDEN HARRISON</creator><creator>DAVID BRENT RAWLINS</creator><creator>NICOLE CATHLEEN GOODWIN</creator><scope>EVB</scope></search><sort><creationdate>20211214</creationdate><title>Inibidores de cotransportador 1 de glicose de sódio e composição farmacêutica que os compreende</title><author>ZAMBROWICZ BRIAN ; KENNETH GORDON CARSON ; STROBEL ERIC ; BRYCE ALDEN HARRISON ; DAVID BRENT RAWLINS ; NICOLE CATHLEEN GOODWIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112015011298B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZAMBROWICZ BRIAN</creatorcontrib><creatorcontrib>KENNETH GORDON CARSON</creatorcontrib><creatorcontrib>STROBEL ERIC</creatorcontrib><creatorcontrib>BRYCE ALDEN HARRISON</creatorcontrib><creatorcontrib>DAVID BRENT RAWLINS</creatorcontrib><creatorcontrib>NICOLE CATHLEEN GOODWIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZAMBROWICZ BRIAN</au><au>KENNETH GORDON CARSON</au><au>STROBEL ERIC</au><au>BRYCE ALDEN HARRISON</au><au>DAVID BRENT RAWLINS</au><au>NICOLE CATHLEEN GOODWIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inibidores de cotransportador 1 de glicose de sódio e composição farmacêutica que os compreende</title><date>2021-12-14</date><risdate>2021</risdate><abstract>inibidores de cotransportador 1 de glicose de sódio. a presente invenção refere-se a inibidores de cotransportador 1 de glicose de sódio (sglt1), composições que os compreendem, e métodos de seu emprego para tratar doenças e distúrbios tais como diabetes. compostos particulares são da fórmula (i): (i) cujos vários substituintes estão definidos aqui. Inhibitors of sodium glucose cotransporter 1 (SGLT1), compositions comprising them, and methods of their use to treat diseases and disorders such as diabetes are disclosed. Particular compounds are of the formula:the various substituents of which are defined herein.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	por
recordid	cdi_epo_espacenet_BR112015011298B1
source	esp@cenet
subjects	CHEMISTRY DERIVATIVES THEREOF HETEROCYCLIC COMPOUNDS METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY SUGARS
title	Inibidores de cotransportador 1 de glicose de sódio e composição farmacêutica que os compreende
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T17%3A47%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZAMBROWICZ%20BRIAN&rft.date=2021-12-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112015011298B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true